RE:RE:Management Shakeup: New CFO Softgels are a good product for OILS indeed. Building on its strongest assets.
Current clientele using OILS vapes will appreciate this easier way to consume their medical cannabis on the go without the problems of combustion or the handling of oil, with possibly a longer-lasting effect.
This new product, a natural complement to the vapes and oils current offer, will consolidate the present clientele and reach out to a new one who wants to try cannabis on their own terms, that is in a very simple way and with the assurance of dosage control.
Moreover, OILS clearly has an edge in the way it is testing flavours with its prospective clientele. Those flavours it has developed successfully for its vapes might prove handy here once again.
The misery LABS, HEXO and others are currently enduring is not about to stop. OILS is slowly eating them alive. At this juncture it is all about the top line (revenues), not yet the bottom line (profits). The survival of the fittest.